← All stocks

Cibus, Inc.

CBUS Net buying
CIK 0001705843 #4190 in the set updated 21 Sep 2026
Bought (120 mo)
$6.95M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.54M
$60.02K on a plan · $2.65M straight out of an exercise
Sold at will
$2.83M
133 of 165 sales
Net
+$1.41M
+$4.12M against sales at will

By person

35 insiders · 191 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RIGGS RORY B
Director
$5.50M (2)
+$5.50M
18,910,112
34.85%
$28.08M
+675.5%
Voytas Daniel F
Chief Science Officer
$1.48M (22) scheduled
−$1.48M
0
0.0000%
$0.00
Godard Alain
Director
$1.27M (10) scheduled
−$1.27M
33,320
0.0614%
$49.48K
−15.0%
Cellectis S.A.
10% owner
$1.23M (1)
+$1.23M
23,963,175
44.16%
$35.59M
+8.4%
Sahoo Manoj
Chief Commercial Officer
$581.67K (13)
−$581.67K
65,323
0.1204%
$97.00K
−33.3%
Corkal Bryan W.J.
Chief Financial Officer
$501.84K (6)
−$501.84K
73,807
0.1360%
$109.60K
−25.1%
Ribeill Yves J
Director
$415.44K (20)
−$415.44K
99,225
0.1829%
$147.35K
Arbadji Michel
Director of Business Developme
$290.93K (3) scheduled
−$290.93K
24,990
0.0461%
$37.11K
−15.0%
Tripodi Federico A.
Chief Executive Officer
$286.50K (1)
−$286.50K
181,300
0.3341%
$269.23K
−7.5%
Blome James
Chief Executive Officer
$247.83K (8)
−$247.83K
186,282
0.3433%
$276.63K
+13.3%
Prante Gerhard
Director
$220.71K (60)
−$220.71K
104,945
0.1934%
$155.84K
Choulika Andre
Director
$65.49K (2)
−$65.49K
130,815
0.2411%
$194.26K
−16.6%
Koschak William
Chief Financial Officer
$64.11K (1)
+$64.11K
19,506
0.0359%
$28.97K
Gocal Gregory Francis William
Chief Scientific Officer & EVP
$60.02K (3) scheduled
−$60.02K
422,890
0.7793%
$627.99K
NEUGENT CHRISTOPHER J
Director
$59.29K (1)
+$59.29K
46,804
0.0863%
$69.50K
+836.1%
Carr Michael A.
President and CEO
$39.78K (1)
+$39.78K
33,174
0.0611%
$49.26K
Kozicz-Stankiewicz Anna Ewa
Director
$31.78K (6)
−$31.78K
24,089
0.0444%
$35.77K
+22.9%
Broos Carlo
CFO
$24.63K (1)
−$24.63K
228,472
0.4210%
$339.28K
+72.4%
Dumont Philippe
Director
$35.90K (3)
$54.74K (8)
−$18.84K
27,614
0.0509%
$41.01K
Frey Travis
Chief Technology Officer
$16.73K (15)
+$16.73K
19,060
0.0351%
$28.30K
Bowers Glenn R
Vice President of Breeding
$8.24K (1)
−$8.24K
8,617
0.0159%
$12.80K
−4.7%
Sauer Noel
Sr VP, Research
$5.94 (1)
−$5.94
139,879
0.2578%
$207.72K
+49.2%
Finn Jonathan
10% owner
2,796,674
5.15%
$4.15M
+231,797%
Lehmann Jean-Pierre Jules
Director
2,450,975
4.52%
$3.64M
Finn Mark Terrence
Director
1,287,721
2.37%
$1.91M
+1,875%
Wichner Craig
CEO
894,309
1.65%
$1.33M
Beetham Peter
Interim CEO, Pres & COO
686,825
1.27%
$1.02M
King Wade Hampton
Chief Financial Officer
220,656
0.4066%
$327.67K
Stokes Jason
CAO, Gen Csl & Corp Secy
167,865
0.3093%
$249.28K
+68.8%
Walker Keith Allen
Director
98,701
0.1819%
$146.57K
Urban Thomas
Director
64,748
0.1193%
$96.15K
Jonathan Fassberg
Director
26,804
0.0494%
$39.80K
Reiter Sarah
Chief Business Officer
21,101
0.0389%
$31.33K
+122.1%
Frimerman Debra H
General Counsel and Secretary
18,772
0.0346%
$27.88K
Nelson Kimberly K.
Director
7,204
0.0133%
$10.70K
Insider
Date
Role
Action
Shares
Price
Amount
Voytas Daniel F
29 Apr 2019
Chief Science Officer
Sold after exercise
3,750
$16.31
$61.15K
Voytas Daniel F
25 Feb 2019
Chief Science Officer
Sold after exercise
3,977
$16.00
$63.63K
Voytas Daniel F
1 Feb 2019
Chief Science Officer
Sold after exercise
4,087
$13.00
$53.13K
Voytas Daniel F
31 Jan 2019
Chief Science Officer
Sold after exercise
4,083
$13.00
$53.08K
Voytas Daniel F
18 Dec 2018
Chief Science Officer
Sold after exercise
4,083
$13.00
$53.08K
Voytas Daniel F
8 Nov 2018
Chief Science Officer
Sold after exercise
4,083
$13.00
$53.08K
Voytas Daniel F
9 Oct 2018
Chief Science Officer
Sold after exercise
4,083
$13.84
$56.51K
Voytas Daniel F
20 Sep 2018
Chief Science Officer
Sold after exercise
4,666
$16.00
$74.66K
Voytas Daniel F
10 Sep 2018
Chief Science Officer
Sold after exercise
4,083
$16.13
$65.84K
Voytas Daniel F
20 Aug 2018
Chief Science Officer
Sold after exercise
4,666
$17.31
$80.77K
Voytas Daniel F
8 Aug 2018
Chief Science Officer
Sold after exercise
4,083
$17.48
$71.37K
Voytas Daniel F
20 Jul 2018
Chief Science Officer
Sold after exercise
4,666
$17.94
$83.71K
Voytas Daniel F
9 Jul 2018
Chief Science Officer
Sold after exercise
4,083
$17.84
$72.82K
Arbadji Michel
20 Jun 2018
Director of Business Developme
Sold after exercise
6,500
$22.00
$143.00K
Voytas Daniel F
20 Jun 2018
Chief Science Officer
Sold after exercise
4,666
$20.56
$95.91K
Voytas Daniel F
21 May 2018
Chief Science Officer
Sold after exercise
4,666
$16.63
$77.59K
Voytas Daniel F
8 May 2018
Chief Science Officer
Sold after exercise
4,083
$15.58
$63.60K
Voytas Daniel F
20 Apr 2018
Chief Science Officer
Sold after exercise
4,666
$16.87
$78.70K
Voytas Daniel F
9 Apr 2018
Chief Science Officer
Sold after exercise
4,083
$14.38
$58.73K
Voytas Daniel F
20 Mar 2018
Chief Science Officer
Sold after exercise
4,666
$17.91
$83.56K
Godard Alain
12 Mar 2018
Director
Sold after exercise
10,000
$19.00
$190.00K
Godard Alain
9 Mar 2018
Director
Sold after exercise
10,000
$19.00
$190.00K
Godard Alain
5 Mar 2018
Director
Sold after exercise
10,000
$19.00
$190.00K
Arbadji Michel
28 Feb 2018
Director of Business Developme
Sold after exercise
3,500
$18.63
$65.22K
Godard Alain
26 Feb 2018
Director
Sold after exercise
10,000
$19.03
$190.26K
Godard Alain
21 Feb 2018
Director
Sold after exercise
13,300
$19.19
$255.20K
Godard Alain
20 Feb 2018
Director
Sold after exercise
600
$21.90
$13.14K
Godard Alain
20 Feb 2018
Director
Sold after exercise
1,900
$21.23
$40.34K
Godard Alain
20 Feb 2018
Director
Sold after exercise
3,625
$20.23
$73.32K

What was left out

Form 4 filings counted 302
Amendments (4/A) skipped 16
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 29
Sales at will 133
Transactions with no price 0
Shares from compensation/vesting 36,995,812
Sales filed before the plan box existed 71
History held since 27 Jul 2017